alphaveMEDICAMEQ₹302.00

Medicamen Biotech Limited

₹ CrorePeersMEDICO AAREYDRUGS NECLIFE HALEOSLABS ALBERTDAVD NATCAPSUQ VALIANTLAB BALPHARMAMcap ₹410 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	91.0	86.1	84.1	84.1
+ Other Intangibles	0.9	0.7	0.6	0.6
+ Long-term Loans	1.2	1.2	5.0	5.0
Non-current Financial Assets	1.2	1.2	5.0	5.0
+ Deferred Tax Assets	2.5	2.8	3.2	3.2
+ Other Non-current Assets	39.4	41.4	55.5	55.5
Total Non-current Assets	134.9	132.3	148.3	148.3
Current Assets
+ Inventories	59.4	62.1	70.1	70.1
+ Trade Receivables	55.3	68.9	81.8	81.8
+ Cash & Cash Equivalents	14.8	3.8	31.3	31.3
+ Other Bank Balances	0.0	0.0	2.7	2.7
+ Short-term Loans	4.5	3.1	37.9	37.9
+ Other Current Financial Assets	—	26.7	—	—
Current Financial Assets	74.5	102.4	153.7	153.7
+ Other Current Assets	25.7	—	—	—
Total Current Assets	159.6	164.5	223.7	223.7
Total Assets	294.5	296.9	372.0	372.0
Equity
+ Equity Share Capital	12.7	12.7	13.6	13.6
+ Other Equity / Reserves	187.8	200.1	262.0	262.0
Equity — Owners of Parent	200.5	212.8	275.6	275.6
Total Equity	200.5	212.8	275.6	275.6
Liabilities
+ Borrowings — Non-current	1.3	3.7	6.2	6.2
Non-current Financial Liabilities	1.3	3.7	6.2	6.2
+ Provisions — Non-current	1.8	2.2	2.4	2.4
+ Deferred Tax Liabilities	—	-0.0	—	—
Non-current Liabilities	3.0	5.9	8.5	8.5
+ Borrowings — Current	29.6	29.5	41.6	41.6
+ Trade Payables	45.4	42.6	40.0	40.0
+ Other Current Financial Liab	11.1	1.9	2.5	2.5
Current Financial Liabilities	86.0	74.0	84.1	84.1
+ Provisions — Current	0.9	0.8	1.2	1.2
+ Current Tax Liabilities	4.1	3.3	2.6	2.6
Current Liabilities	91.0	78.2	87.9	87.9
Total Liabilities	94.0	84.1	96.4	96.4
Total Equity & Liabilities	294.5	296.9	372.0	372.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.0	1.0	1.0
+ Dues to Other Creditors — Current	—	42.6	39.0	39.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.